Anixa Biosciences (ANIX) 10-Q2011 Q1 Quarterly report

Filed: 17 Mar 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: absence, Additionally, advanced, allocated, Android, breadth, delivered, detail, easily, element, evidenced, extended, holder, intellectual, introducing, law, loaded, longer, moved, placement, policy, popular, prospectively, ray, rescheduled, Subtopic, superior, TFT, thereof, thousandth, TPE, undelivered, Vendor, VSOE, warrant, write, written

Removed: accretion, activity, agency, applied, approval, approximated, area, arrival, authoritative, beginning, billed, book, delayed, demand, determination, direct, discussed, entering, exercisable, expanding, expire, filer, intent, labor, length, line, marketable, maturity, noted, overhead, Oversea, permitted, rapidly, recognition, reconciliation, reduction, regularly, reserved, source, stated, team, thinner, travel, twelve

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ANIX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

Statement of Chief Financial Officer

Pursuant to Section 1350 of Title 18 of the United States Code

Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, Henry P. Herms, the Vice President - Finance and Chief Financial Officer of CopyTele, Inc., hereby certifies that:

1.	The Company's Form 10-Q Quarterly Report for the period ended January 31, 2011 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	/s/ Henry P. Herms
	Henry P. Herms
	Vice President - Finance and
March 17, 2011	Chief Financial Officer